Scherer cares for patients living with rare obesity syndromes and recounts a recent particular struggle to treat two male patients ages 20 and 23 years with AS, who did not respond to multimodal obesity therapy including GLP-1RAs
Switching from Tirzepatide to Retatrutide may be possible once Retatrutide receives approval, but discuss this thoroughly with your healthcare provider first
Convert fat into usable energy
Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knofel MT, et al
the Oil Red O and BODPIY staining showed that in cholesterol-stimulated INS-1 cells, lipid droplet accumulation was markedly increased compared to that in the control group while it decreased after EX-4 treatment alone or cholesterol co-treatment compared with that in the single cholesterol group (Figure 1I)